Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 128
Filtrer
1.
Clin Exp Dermatol ; 47(2): 399-403, 2022 Feb.
Article de Anglais | MEDLINE | ID: mdl-34411313

RÉSUMÉ

BACKGROUND: Acute pseudoperniosis (PP) has a recognized association with COVID-19 and tends to occur without cold precipitation in young, healthy patients, often without a clear history of COVID-19. These lesions usually resolve within 2 weeks and without long-term sequelae. In the early months of 2021, patients with delayed and protracted PP began to emerge. We have called this presentation 'tardive COVID-19 PP (TCPP)'. AIM: To consolidate and expand knowledge on TCPP, we describe the clinical characteristics, treatments and outcomes of 16 patients with TCPP who were reviewed by our outpatient dermatology service. RESULTS: The initial clinical manifestations were erythema, swelling and PP of the fingers in 56.2%, and of the toes in 31.2%, desquamation in 56.2% and acrocyanosis in 12.5%. Ten patients had eventual involvement of all acral sites. The median duration of symptoms was 191 days. Six patients reported close contact with a confirmed or suspected case of COVID-19, but only two had positive COVID-19 tests. Four patients experienced complete or almost complete resolution of symptoms, while the rest remain under active treatment. CONCLUSION: Unlike acute PP, TCPP has a protracted and delayed presentation that is typically associated with profound acrocyanosis. Patients with TCPP represent a new phenomenon that is part of the post-COVID-19 syndrome, with risk factors and pathophysiology that are not yet fully understood. Our data indicate that likely predisposing factors for developing TCPP include young age, a preceding history of cold intolerance and an arachnodactyloid phenotype. Anorexia, connective tissue disorders or sickle cell trait may also predispose to TCPP. In addition, low titre antinuclear antibody positivity, the presence of cryoglobulins, or low complement levels may represent further risk factors. Finally, prolonged low temperatures are also likely to be contributing to the symptoms.


Sujet(s)
COVID-19/complications , Érythème pernio/diagnostic , Dermatoses du pied/diagnostic , Dermatoses du pied/virologie , Dermatoses de la main/diagnostic , Dermatoses de la main/virologie , Maladie aigüe , Adolescent , Adulte , Sujet âgé , COVID-19/diagnostic , COVID-19/thérapie , Érythème pernio/thérapie , Érythème pernio/virologie , Études de cohortes , Femelle , Humains , Mâle , Adulte d'âge moyen , Facteurs temps , Jeune adulte , Syndrome de post-COVID-19
2.
Clin Dermatol ; 39(1): 84-91, 2021.
Article de Anglais | MEDLINE | ID: mdl-33972057

RÉSUMÉ

The emergence of the coronavirus disease 2019 (COVID-19) worldwide pandemic has been associated with a new constellation of cutaneous features in children. Among the unusual dermatologic presentations are the so-called COVID toes, inflammatory nodules of the feet and toes, sometimes involving the hands and fingers. These lesions mimic acral pernio, the synonym being chilblains. Unlike adult patients with COVID toes, children are less likely to manifest symptomatic COVID-19. Although a few studies have found some linkage to COVID-19 through the serum IgA or IgG severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein, other studies have no demonstrable linkage suggesting that barefoot children in cold weather develop such lesions. It appears that the chilblain-like lesions related to the period of the COVID-19 pandemic may reflect a brisk immune response portending a good prognosis and perhaps some form of innate immunity. The possible need to screen for coagulopathy is unclear, but this has been suggested in one report. Until we fully understand the pattern of immune response to COVID-19, questions may persist as to how disease manifestations are linked to SARS-CoV-2 exposures.


Sujet(s)
COVID-19/complications , Érythème pernio/virologie , Dermatoses du pied/virologie , Dermatoses de la main/virologie , Adolescent , Érythème pernio/immunologie , Enfant , Enfant d'âge préscolaire , Doigts , Dermatoses du pied/immunologie , Dermatoses de la main/immunologie , Humains , Nourrisson , Nouveau-né , SARS-CoV-2 , Orteils
5.
Top Companion Anim Med ; 41: 100475, 2020 Nov.
Article de Anglais | MEDLINE | ID: mdl-32966900

RÉSUMÉ

This report aims to describe one case of plasma cell pododermatitis associated with feline leukemia virus (FeLV) and concomitant feline immunodeficiency virus (FIV) infection in a cat. A 2-year-old, intact male, mixed-breed cat was presented with alopecia, skin peeling, and erythematous swelling in the left metacarpal paw pad. Swelling, softening, ulceration with secondary crusts, and erythematous to violaceous discoloration were observed in multiple metacarpal, metatarsal, and digital paw pads. Complete blood count and serum biochemistry were analyzed. FeLV antigenemia and FIV seropositivity were assessed by immunoassay (enzyme-linked immunosorbent assay). Nested-PCR was used to detect FIV and FeLV proviral DNA in blood cells. Histopathological examination and anti-FeLV and anti-FIV immunohistochemical were performed on paw pad biopsies. According to clinical and histopathological findings, a diagnosis of plasma cell pododermatitis was made. The cat was FIV and FeLV seropositive. The immunohistochemical of paw pad biopsies revealed FeLV positivity and FIV negativity. This study provides reference for further investigations about feline plasma cell pododermatitis and highlights retrovirus infection as a potential factor associated with this disease.


Sujet(s)
Maladies des chats/diagnostic , Syndrome d'immunodéficience acquise féline/sang , Dermatoses du pied/médecine vétérinaire , Infections à Retroviridae/médecine vétérinaire , Infections à virus oncogènes/médecine vétérinaire , Animaux , Maladies des chats/virologie , Chats , Co-infection/médecine vétérinaire , Co-infection/virologie , Dermatoses du pied/virologie , Virus de l'immunodéficience féline/isolement et purification , Virus de la leucémie féline/isolement et purification , Mâle , Plasmocytes , Infections à Retroviridae/sang , Infections à virus oncogènes/sang
11.
J Cosmet Dermatol ; 19(4): 946-950, 2020 Apr.
Article de Anglais | MEDLINE | ID: mdl-31479180

RÉSUMÉ

INTRODUCTION: Plantar warts are associated with high transmissibility and morbidity. Among the available therapeutic options, none is uniformly effective or virucidal. Salicylic acid is the first-line therapy but approximately one-third of lesions could not resolve and become recalcitrant despite repeated treatment. Cryotherapy is widely accessible with low cost but may be complicated by pain, blister formation, hemorrhage, infection, excessive granulation tissue formation, and hyper-/hypo-pigmentation. Hence, alternative treatment modalities are essential. METHODS: Three patients with debilitating plantar warts refractory or intolerant to cryotherapy were treated with a course of Zijinding (a traditional Chinese medicine preparation) paste prepared with white vinegar. RESULTS: All three patients showed excellent clinical response with Zijinding application with evolution of lesions to scabs and subsequently healthy skin within 1.5 to 5 months of treatment. Treatment was well tolerated and had no significant side effects with excellent compliance recorded for all three patients. There was no relapse for at least 10 months after stopping the treatment. CONCLUSION: Topical Zijinding could be a promising alternative modality for the treatment of plantar warts. Further clinical trials on the comparison of Zijinding and other treatment modalities of plantar warts are warranted. Further studies are required to investigate the mechanism of action of Zijinding and to isolate the active ingredient.


Sujet(s)
Médicaments issus de plantes chinoises/administration et posologie , Dermatoses du pied/thérapie , Prévention secondaire/méthodes , Verrues/thérapie , Administration par voie cutanée , Adulte , Cryothérapie , Femelle , Dermatoses du pied/virologie , Humains , Mâle , Résultat thérapeutique , Verrues/virologie
12.
Pediatr Dermatol ; 36(3): 406-407, 2019 May.
Article de Anglais | MEDLINE | ID: mdl-30859616

RÉSUMÉ

Herpetic whitlow of the toe is a common infection in an uncommon location, leading it to be frequently misdiagnosed; however, as the virus responds well to conservative management or antivirals alone, proper identification is necessary to prevent unnecessary interventions. We present a case of herpetic whitlow of the toe with an unusually ominous appearance in a previously healthy and otherwise well-appearing child. This case illustrates the spectrum of herpetic whitlow's clinical presentations and enourages consideration of the disease even for atypical location and severity.


Sujet(s)
Cellulite sous-cutanée/virologie , Dermatoses du pied/virologie , Herpès/diagnostic , Herpèsvirus humain de type 1 , Aciclovir/usage thérapeutique , Antiviraux/usage thérapeutique , Cellulite sous-cutanée/traitement médicamenteux , Cellulite sous-cutanée/anatomopathologie , Enfant d'âge préscolaire , Dermatoses du pied/traitement médicamenteux , Dermatoses du pied/anatomopathologie , Herpès/traitement médicamenteux , Humains , Mâle , Orteils
13.
Dermatol Online J ; 24(4)2018 Apr 15.
Article de Anglais | MEDLINE | ID: mdl-29906005

RÉSUMÉ

Papular purpuric gloves and socks syndrome (PPGSS) is a self-limited exanthem that presents as painful or pruritic edema, erythema, petechiae, and purpura of the palms and soles with occasional extension to the dorsal hands and feet. The majority of PPGSS cases reported in the literature are associated with parvovirus B19 and occur in children and young adults. In a recent literature search, there were 11 PPGSS cases in adults with none reporting Epstein-Barr virus (EBV) as a viral etiology. However, there have been PPGSS cases related to EBV in children. We report the case of a 72-year-old man with PPGSS associated with Epstein-Barr virus. This case report serves as a reminder that PPGSS can present not only in the setting of pediatric and young adult parvovirus B19 infection, but also in immunocompetent adults with other viral infections.


Sujet(s)
Oedème/virologie , Infections à virus Epstein-Barr/complications , Exanthème/virologie , Dermatoses du pied/virologie , Dermatoses de la main/virologie , Prurit/virologie , Sujet âgé , Infections à virus Epstein-Barr/diagnostic , Humains , Mâle , Syndrome
14.
Trials ; 18(1): 263, 2017 06 07.
Article de Anglais | MEDLINE | ID: mdl-28592299

RÉSUMÉ

BACKGROUND: Despite the lack of scientific studies on biofield therapies, they are widely acclaimed by patients. The mechanisms of action are not explained by current allopathic medical approaches. Warts are common and contagious viral lesions that may be refractory to standard dermatologic treatments such as cryotherapy, laser therapy, and keratolytic ointments. Biofield therapies are efficient in various pathologies. Their ability to treat warts has never been demonstrated in a scientific study with a robust methodology. Patients with refractory warts often place their trust in these alternative therapies because of the poor results obtained from traditional medicine. We propose a prospective, randomized, single-blind, assessor-blind trial to evaluate the efficacy of treatment of warts by biofield therapy. METHODS/DESIGN: Subjects with warts on their feet or hands will be randomized into two groups: real biofield therapy versus sham therapy. The diagnosis will be made at the time of inclusion, and follow-up will take place in week 3. Comparison of pictures of the warts at baseline and after 3 weeks will be used as the primary outcome measure. The hypothesis is that the extent of the disappearance of the original wart in the group treated by real biofield therapy will be 70% and that it will be 30% in the group treated by sham therapy. Using 90% power and an alpha risk of 5%, 31 subjects are required in each group for a two-tailed proportion comparison test. DISCUSSION: To our knowledge, this is the first study to evaluate the efficacy of biofield therapy on warts. Therefore, the aim of this study is to extend knowledge of biofield therapy to another area of medicine such as dermatology and to propose complementary or alternative practices to improve patient well-being. The main strength of the study is that it is a randomized, single-blind, assessor-blind, placebo-controlled study. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT02773719 . Registered on 22 April 2016.


Sujet(s)
Dermatoses du pied/thérapie , Dermatoses de la main/thérapie , Toucher thérapeutique/méthodes , Verrues/thérapie , Protocoles cliniques , Dermatoses du pied/diagnostic , Dermatoses du pied/virologie , France , Dermatoses de la main/diagnostic , Dermatoses de la main/virologie , Humains , Placebo , Études prospectives , Induction de rémission , Plan de recherche , Méthode en simple aveugle , Toucher thérapeutique/effets indésirables , Facteurs temps , Résultat thérapeutique , Verrues/diagnostic , Verrues/virologie
15.
Clin Dermatol ; 35(1): 40-49, 2017.
Article de Anglais | MEDLINE | ID: mdl-27938811

RÉSUMÉ

Viruses are considered intracellular obligates with a nucleic acid RNA or DNA. They have the ability to encode proteins involved in viral replication and production of the protective coat within the host cells but require host cell ribosomes and mitochondria for translation. The members of the families Herpesviridae, Poxviridae, Papovaviridae, and Picornaviridae are the most commonly known agents for cutaneous viral diseases, but other virus families, such as Adenoviridae, Togaviridae, Parvoviridae, Paramyxoviridae, Flaviviridae, and Hepadnaviridae, can also infect the skin. Herpetic whitlow should be considered under the title of special viral infections of the acral region, where surgical incision is not recommended; along with verruca plantaris with its resistance to treatment and the search for a new group of treatments, including human papillomavirus vaccines; HIV with maculopapular eruptions and palmoplantar desquamation; orf and milker's nodule with its nodular lesions; papular-purpuric gloves and socks syndrome with its typical clinical presentation; necrolytic acral erythema with its relationship with zinc; and hand, foot, and mouth disease with its characteristics of causing infection with its strains, with high risk for complication.


Sujet(s)
Dermatoses du pied/virologie , Dermatoses de la main/virologie , Infections à Herpesviridae/complications , Verrues/complications , Animaux , Ecthyma contagieux/complications , Infections à Flaviviridae/complications , Infections à VIH/complications , Syndrome mains-pieds-bouche/complications , Humains , Molluscum contagiosum/complications , Infections à Parvoviridae/complications , Ovis
16.
Dermatol Ther ; 30(2)2017 Mar.
Article de Anglais | MEDLINE | ID: mdl-27917575

RÉSUMÉ

Treating plantar, periungual, and external genital warts can be challenging. A prospective study from four centers in Italy evaluated 37 immunocompetent patients with single or multiple warts and treated each lesion with a nitric-zinc topical solution composed of organic and inorganic acids meant to devitalize tissue and destroy HPV DNA in infected keratinocytes. Thirty of the 37 patients had external genital warts, two had plantar warts, two had palm and finger warts, and three had subungual warts for a total of 55 lesions treated. Nitric-zinc aqueous solution was applied over each wart utilizing a 30 µL capillary tube until a whitening response was observed. Additional applications as needed were accomplished at 2-week intervals until the wart was gone. In those with hand, plantar, and subungual warts, there was a 100% clearance after two to three sessions. Three with external genital warts had only a partial response and one no benefit after four applications. Thus, this approach was effective in external genital and other "difficult-to-treat" warts in 90% of patients after one to four applications. It also was easy to use with no adverse events noted.


Sujet(s)
Acides noncarboxyliques/administration et posologie , Acides carboxyliques/administration et posologie , Condylomes acuminés/traitement médicamenteux , Produits dermatologiques/administration et posologie , Dermatoses du pied/traitement médicamenteux , Dermatoses de la main/traitement médicamenteux , Verrues/traitement médicamenteux , Acides noncarboxyliques/effets indésirables , Administration par voie cutanée , Acides carboxyliques/effets indésirables , Condylomes acuminés/diagnostic , Condylomes acuminés/virologie , Produits dermatologiques/effets indésirables , Calendrier d'administration des médicaments , Préparation de médicament , Dermatoses du pied/diagnostic , Dermatoses du pied/virologie , Dermatoses de la main/diagnostic , Dermatoses de la main/virologie , Humains , Induction de rémission , Facteurs temps , Résultat thérapeutique , Verrues/diagnostic , Verrues/virologie
17.
Clin Exp Dermatol ; 42(1): 58-60, 2017 Jan.
Article de Anglais | MEDLINE | ID: mdl-27900796

RÉSUMÉ

Parvovirus B19 infection can cause a wide range of cutaneous manifestations, including papular-purpuric gloves-and-socks syndrome (PPGSS) and petechial bathing trunk eruption. We report a case of an immunocompetent woman with a primary parvovirus B19 infection presenting as concurrent PPGSS and petechial bathing trunk eruption. Parvovirus B19 seroconversion was confirmed several days after the onset of the clinical manifestations. The coexistence of these two cutaneous manifestations of primary parvovirus B19 infection has rarely been reported in the literature. It is important to recognize parvovirus B19 infection early, based on the cutaneous manifestations, to avoid potentially serious systemic complications in susceptible individuals.


Sujet(s)
ADN viral/analyse , Derme/anatomopathologie , Érythème infectieux/diagnostic , Dermatoses du pied/diagnostic , Dermatoses de la main/diagnostic , Parvovirus humain B19/génétique , Tronc/anatomopathologie , Biopsie , Derme/virologie , Érythème infectieux/virologie , Femelle , Dermatoses du pied/virologie , Dermatoses de la main/virologie , Humains , Adulte d'âge moyen , Parvovirus humain B19/isolement et purification , Réaction de polymérisation en chaîne , Syndrome
18.
Avian Pathol ; 45(5): 582-92, 2016 Oct.
Article de Anglais | MEDLINE | ID: mdl-27215315

RÉSUMÉ

Marek's disease virus (MDV), the aetiological agent of Mareks' disease (MD), is a highly cell-associated oncogenic α-herpesvirus that replicates in chicken lymphocytes and establishes a latent infection within CD4(+) T cells. We investigated the possible effect of MDV infection on the exacerbation of necrotic dermatitis in the combs of MD-susceptible (72) and MD-resistant (63) chicken lines at 21 days post infection. MDV-infected birds of line 63 are relatively resistant to tumour development but exhibit an unusual necrosis of combs, wattles, and footpads that is intensified when infected with MDV. Chickens from line 72, on the other hand, are highly susceptible to MDV infection and tumour development. Real-Time PCR analysis revealed that IL-6, IL-8, IL-12, IL-18, iNOS, and IFNγ were all up regulated in the comb tissues of MDV-infected susceptible line 72 with no visible necrotic damage. With the exception of IL-8 and iNOS, the expression of all the other tested genes was barely detected in the necrotic combs of the resistant line 63. Real-Time PCR analysis revealed the MDV meq oncogene transcripts in the spleen tissues of both infected lines but in the comb tissues of only the susceptible line 72. A significant infiltration of macrophages and lymphocytes was detected in the comb tissues of both resistant and susceptible lines. Histopathological analysis also showed thinning and erosion of epidermis and inflammation, lympho-plasmocytic infiltration, heterophilic, and histocytic cellulitis within the connective tissues of the necrotic combs. Gram stain of the sectioned frozen comb samples exposed the presence of Gram-positive micrococcus.


Sujet(s)
Poulets/virologie , Dermatoses du pied/médecine vétérinaire , Herpèsvirus aviaire de type 2/immunologie , Maladie de Marek/virologie , Maladies de la volaille/virologie , Animaux , Marqueurs biologiques/analyse , Poulets/génétique , Poulets/immunologie , Dermatoses du pied/immunologie , Dermatoses du pied/anatomopathologie , Dermatoses du pied/virologie , Analyse de profil d'expression de gènes/médecine vétérinaire , Herpèsvirus aviaire de type 2/génétique , Herpèsvirus aviaire de type 2/isolement et purification , Inflammation/médecine vétérinaire , Maladie de Marek/immunologie , Maladie de Marek/anatomopathologie , Nécrose/médecine vétérinaire , Maladies de la volaille/immunologie , Maladies de la volaille/anatomopathologie , Rate/anatomopathologie , Rate/virologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE